Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperfractionated RT +/- Cisplatin in Head and Neck Cancer
NCT00002654Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Apr 1994
- Primary completion
- Mar 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Swiss Group for Clinical Cancer Research. Primary endpoint: Time to Treatment Failure. Started Apr 1994; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00002654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002654.